Posts

Showing posts with the label Amitriptyline

Amitriptyline: A Tricyclic Antidepressant Developed For the Treatment of Anxiety and Depression

Image
   Amitriptyline Market Amitriptyline belongs to the tricyclic antidepressant family. The drug was developed for the treatment of anxiety and depression. It works on the central nervous system (CNS) to increase levels of certain chemicals in the brain. It is also effective in pain management when used in low dosage.    Other uses of the drug include, anxiety, chronic pain (diabetic neuropathy, fibromyalgia), insomnia, irritable bowel syndrome, interstitial cystitis (bladder pain syndrome), migraine prophylaxis, post-traumatic stress disorder, postherpetic neuralgia, and sialorrhea. However, there is a lack of evidence that amitriptyline has any beneficial effect on sleep in insomnia. The global amitriptyline market is estimated to be valued at US$ 527.4 million in 2020 and is expected to exhibit a CAGR of 5.3% during the forecast period (2020-2027).    Amitriptyline  is commonly prescribed for the treatment of depression and nerve pain. It is also used to treat bedwetting and nocturnal

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides